What is EDAP's health score?

EDAP TMS SA (EDAP) has a TradeApes health score of 41 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is EDAP's estimated fair value?

Based on our 5-year discounted cash flow model, EDAP TMS SA's estimated fair value is $3.46 per share, representing a -19.9% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is EDAP undervalued or overvalued?

Our model currently rates EDAP as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

2 free score cards remaining

EDAP TMS SA (EDAP)

Healthcare Fair Value low weak

$4.32

Updated: 2026-07-18

TradeApes Score

Financial Strength

35 Weak

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

50 Mixed

Risk Management

50 Mixed

Est. Fair Value $3.46

DCF Upside -19.9%

Sector Rank #6457 of 12113

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Industry Related Stocks

Adagio Medical Holdings, Inc. (ADGM) ADM TRONICS UNLIMITED, INC. (ADMT) AETHLON MEDICAL INC (AEMD) Axe Compute Inc. (AGPU) ALIGN TECHNOLOGY INC (ALGN) ALLURION TECHNOLOGIES, INC. (ALUR)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.